BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36653583)

  • 21. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
    Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
    Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA-RNCR3 overexpression deleteriously affects the growth of glioblastoma cells through miR-185-5p/Krüppel-like factor 16 axis.
    Zhang L; Cao Y; Wei M; Jiang X; Jia D
    J Cell Biochem; 2018 Nov; 119(11):9081-9089. PubMed ID: 29953649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 25. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
    Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
    J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
    Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
    Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.
    Voce DJ; Bernal GM; Wu L; Crawley CD; Zhang W; Mansour NM; Cahill KE; Szymura SJ; Uppal A; Raleigh DR; Spretz R; Nunez L; Larsen G; Khodarev NN; Weichselbaum RR; Yamini B
    Cancer Res; 2019 May; 79(10):2536-2548. PubMed ID: 30940658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of long non-coding RNA ROR in patient-derived glioblastoma cells.
    Kovalenko TF; Yadav B; Anufrieva KS; Rubtsov YP; Zatsepin TS; Shcherbinina EY; Solyus EM; Staroverov DB; Larionova TD; Latyshev YA; Shakhparonov MI; Pandey AK; Pavlyukov MS
    Biochimie; 2022 Sep; 200():131-139. PubMed ID: 35654242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
    Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
    J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells.
    Wu AC; Yang WB; Chang KY; Lee JS; Liou JP; Su RY; Cheng SM; Hwang DY; Kikkawa U; Hsu TI; Wang CY; Chang WC; Chen PY; Chuang JY
    J Exp Clin Cancer Res; 2022 Feb; 41(1):47. PubMed ID: 35109908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p.
    Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F
    Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dysregulation of Long Non-coding RNAs in Glioblastoma Multiforme and Their Study Through Use of Modern Molecular-Genetic Approaches].
    Večeřa M; Šána J; Bútová R; Reguli Š; Hermanová M; Křen L; Lipina R; Smrčka M; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):168-170. PubMed ID: 29808696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.